Table 2. Demographic information, clinical history, medications, ECG and echocardiographic findings for T. cruzi-infected Stage D at time of recruitment.

	Alive N=30	Died N=20	P-value
Demographics
Age, mean (SD)	62.6 (11.2)	60.3 (9.6)	0.45
Sex, male	16 (53 %)	14 (70 %)	0.24
BMI, mean (SD)*	27.1 (4.4)	24.4 (4.1)	0.04
Overweight or obese*	20 (69 %)	10 (50 %)	0.18
Inpatient at recruitment	21 (70 %)	10 (50 %)	0.15
Medical History by Self-Report**
Hypertension	16 (53 %)	7 (35 %)	0.20
Diabetes Mellitus	3 (10 %)	2 (10 %)	1.00
Coronary Artery Disease	7 (23 %)	2 (10 %)	0.29
Heart Failure	22 (73 %)	14 (70 %)	1.00
Pacemaker	4 (13 %)	2 (10 %)	1.00
Medications**
Beta Blocker	6 (20 %)	4 (20 %)	1.00
ACE inhibitor	10 (33 %)	10 (50 %)	0.24
Angiotensin II Receptor Blockers	3 (10 %)	1 (5 %)	0.64
Anticoagulant	3 (10 %)	2 (10 %)	1.00
Aspirin	21 (70 %)	10 (50 %)	0.15
Nitroglycerin	1 (3 %)	2 (10 %)	0.56
Amiodarone	8 (27 %)	3 (15 %)	0.49
Calcium Channel Blocker	2 (7 %)	1 (5 %)	1.00
Diuretics	11 (37 %)	8 (40 %)	0.81
Digoxin	11 (37 %)	5 (25 %)	0.39
Spironolactone	5 (17 %)	6 (30 %)	0.27
Any medication	26 (87 %)	16 (80 %)	0.70
ECG**
Isolated right bundle branch block	2 (7 %)	5 (25 %)	0.10
RBBB and LAFB	3 (10 %)	1 (5 %)	0.64
Left Bundle Branch Block	4 (13 %)	1 (5 %)	0.33
Atrial fibrillation or flutter	9 (33 %)	9 (45 %)	0.28
Multiple PVC	5 (17 %)	3 (15 %)	0.60
Low voltage	1 (3 %)	1 (5 %)	0.65
Normal ECG	1 (3%)	1 (5%)	0.76
Other Findings
NYHA III or IV	15 (50 %)	12 (60 %)	0.49
Ejection Fraction, median(IQR)	27.5 (20-35)	20 (20-30)	0.13
Segmental Score, median(IQR)	2.0 (1.6-2.3)	2.3 (1.8-2.4)	0.09

BMI = body mass index; RBBB=right bundle branch block; LAFB=left anterior fascicular block; NYHA = New York Heart Association; PVC = premature ventricular contraction. Overweight and obese defined as BMI 25 - 29.9 and ≥ 30, respectively.

^*Weight data missing for one surviving participant

^**Adds up to >100% because some patients had more than one abnormality or drug.